Digital Fertility Support Market Research Report Segmentation by Product & Services (Smartphone Tracking Applications, Wearable devices, Digital Pregnancy Tests, Ovulation Prediction Kits, Telemedicine Services, Web-based Programs, SMS-based Tools, and Others), Type of Support Offered (Preconception Support, Infertility Support, and Pregnancy Support), End-User (Individuals, Couples, Healthcare Providers, and Others), Distribution Channel (Department Store, Healthcare Providers, Retail Pharmacy, E-Commerce, and Others), Mode of Operation (Standalone Applications, and Integrated Platforms); and Region - Size, Share, Growth Analysis | Forecast (2024 2030)

Digital Fertility Support Market Size Projection (2024–2030)

The Digital Fertility Support Market reached a valuation of USD 1.63 billion in 2023 and is expected to achieve a revenue milestone of USD 2.89 billion by the year 2030. Over the forecast period spanning from 2024 to 2030, the market is poised to experience a compound annual growth rate (CAGR) of 8.5%. Key factors contributing to this growth include the decline in fertility rates, the proliferation of fertility clinics worldwide, advancements in technology, and augmented investments, funding, and grants from both public and private sectors in the digital fertility support market.

Digital Fertility Support Market Overview

The escalation in alcohol and drug consumption, heightened stress levels, habitual smoking, obesity, environmental influences, and sedentary lifestyles have all been associated with an elevated risk of infertility. Digital fertility support solutions are services designed to aid in infertility treatment, a condition affecting individuals of reproductive age, both male and female. Major causes of male infertility, such as low sperm concentration or motility, often stem from hormonal imbalances. Studies conducted by the American Society for Reproductive Medicine reveal that approximately 40% of infertile couples attribute their infertility to the male partner, with 85%–90% of these couples undergoing medication or surgical interventions. Consequently, the digital fertility support market is anticipated to expand. Additionally, the surge in infertility rates is correlated with various factors, including sexually transmitted diseases and fertility-related disorders, contributing to the projected growth of the digital fertility support industry.

In the healthcare sector, ongoing research and development in infertility treatment are anticipated to bolster the digital fertility support market. While healthcare services and treatment costs remain high in affluent nations like the United States and Canada, burgeoning economies like India and China present substantial opportunities for key players in the fertility treatment market. Improvements in healthcare infrastructure and the rise in medical tourism, driven by lower treatment costs, are significant factors contributing to growth potential in developing nations globally. These factors collectively contribute to a positive outlook for the global digital fertility support market in the future.

Impact of COVID-19 on the Digital Fertility Support Market

The COVID-19 pandemic has posed a substantial challenge to the global fertility treatment industry. Logistics concerns, prioritization of patients with comorbidities, safeguarding frontline healthcare workers from contamination, and treating patients with the virus are prominent challenges faced by healthcare systems worldwide. In the initial stages of the pandemic, authorities recommended the postponement of all non-essential medical treatments, including fertility procedures. This led to a 90% reduction in the number of individuals undergoing IVF cycles during the pandemic. Fertility clinics experienced disruptions, resulting in the cancellation of IVF treatments and decisions among couples considering such treatments before the pandemic. However, the fertility testing equipment industry saw moderate effects, with increased pregnancy rates in certain regions. At-home digital fertility testing kit sales experienced a modest impact during the pandemic.

Market Drivers:

Growing global infertility cases propel the digital fertility support market

The prevalence of infertility cases is on the rise globally, particularly in countries such as China, the United States, the United Kingdom, and India, driving demand for digital fertility support. With the global fertility rate expected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050, there is an increasing demand for infertility treatment solutions that determine reproductive windows in both males and females. Sedentary lifestyles, heightened stress levels, and obesity contribute to the growing incidence of infertility, leading to a surge in the overall demand for fertility solutions.

Governments worldwide expected to boost funding and enact legislation to support industry growth

Governments and non-profit organizations in developed and developing economies are actively supporting the public by providing affordable fertility treatments. Consequently, substantial investments in the research and development of innovative fertility treatment processes by both public and private entities are expected to positively impact the digital fertility support market's growth over the forecast period.

Market Restraints:

The high cost associated with fertility treatment hinders market development

The substantial costs linked to fertility therapy pose a significant obstacle to the expansion of the digital fertility support industry. In underdeveloped nations, only a small fraction of patients can afford such treatment due to its high cost, limiting the utilization of these technologies and solutions, particularly in developing countries, thereby restraining market growth.

Digital Fertility Support Market - By Product & Services:

• Smartphone Tracking Applications
• Wearable devices
• Digital Pregnancy Tests
• Ovulation Prediction Kits
• Telemedicine Services
• Web-based Programs
• SMS-based Tools
• Others

The segmentation of the digital fertility support market based on products and services includes Smartphone Tracking Applications, Wearable Devices, Digital Pregnancy Tests, Ovulations Prediction Kits, Telemedicine Services, Web-based Programs, SMS-based Tools, and Others. Projections indicate that the Smartphone Tracking Application, Web-based Programs, and SMS-based Tools segments are expected to maintain significant positions during the forecast period. This growth is attributed to technological advancements and the presence of well-established businesses offering diverse products. The heightened focus on expanding through online channels, including new equipment launches, is anticipated to contribute to the segment's growth. Additionally, the Wearable Device segment is expected to experience substantial growth over the forecast period.

Digital Fertility Support Market - By Type of Support Offered:

• Preconception Support
• Infertility Support
• Pregnancy Support

In 2022, the Pregnancy Support segment secured the highest market share, driven by increased awareness of available support and services. The primary drivers for this segment's growth include the rising usage of smart mobile tracking applications and advancements in the development of various fertility services.

Digital Fertility Support Market - By End-User:

• Individuals
• Couples
• Healthcare Providers
• Others

The Couples treatment segment held the highest proportion of the infertility treatment market in 2022. The growth is fueled by declining fertility rates, increased preference for healthcare providers and clinics for treatment and fertility support, and a rise in the availability of various fertility treatment options and clinics globally.

Digital Fertility Support Market - By Distribution Channel:

• Department Store
• Healthcare Providers
• Retail Pharmacy
• E-Commerce
• Others

In 2022, the Healthcare Provider segment captured the highest market share in the global digital menstruation care market, as most individuals prefer consulting doctors and medical staff physically or virtually to address their concerns. Additionally, E-commerce is expected to witness the fastest-growing CAGR during the forecast period due to the proliferation of e-commerce websites and shifts in consumer behaviors.

Digital Fertility Support Market - By Mode of Operation:

• Standalone Applications
• Integrated Platforms

In 2022, the Standalone Applications segment dominated the market, holding the largest market share. Its independence and robust functionality, whether used independently or integrated into other environments without requiring separate software, contribute to the demand for standalone applications in the global digital fertility support market.

Digital Fertility Support Market - By Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa

Geographically, North America leads the fertility industry, attributed to increased campaigns by government and non-profit healthcare groups, such as Fertility Matters Canada, raising awareness about drugs and fertility therapy. The well-developed healthcare infrastructure in North American countries, coupled with the adoption of novel technologies and rising disposable income, contributes to the growing demand for the digital fertility support market. In the coming years, the Asia Pacific fertility industry market is expected to witness significant expansion, with the China fertility industry market likely leading the region in terms of revenue. The prevalence of obesity and chronic illnesses in APAC nations is a driving factor for market growth.

Digital Fertility Support Market - By Companies:

To maintain competitiveness, market players employ various strategies, including mergers and acquisitions, partnerships, and new product releases. Some notable players operating in the digital fertility support market include:

1. Esco Micro Pte. Ltd
2. Ferring B.V.
3. FUJIFILM Irvine Scientific
4. Genea Limited
5. Hamilton Thorne, Inc
6. Ihmedical A/S
7. INVO Bioscience
8. IVFTech Aps
9. Kitazato Corporation
10. LABOTECT GMBH
11. Medgyn Products, Inc
12. Merck KGaA
13. Rocket Medical PLC
14. Somatex Medical Technologies GmbH
15. Thermo Fisher Scientific
16. Vitrolife AB
17. ZEISS International

Latest Industry Developments :

PARTNERSHIP - In 2021, a collaborative agreement was established between Virtus Health and CooperSurgical, aiming to enhance the accessibility of advanced reproductive technologies for couples facing infertility challenges.

PARTNERSHIP - A strategic alliance was forged in 2020 between Invo Bioscience, Trading Pvt Ltd, and Medesole Healthcare, leading global enterprises, to operate specialized invocell fertility clinics within the Indian market.

PARTNERSHIP - In 2020, Hamilton Thorne and Genea Biomedx from Australia joined forces to facilitate the commercialization of Genea Biomedx's reproductive products in the United States and Canada.